NO20090421L - Arylpiperazinderivater og deres anvendelse - Google Patents
Arylpiperazinderivater og deres anvendelseInfo
- Publication number
- NO20090421L NO20090421L NO20090421A NO20090421A NO20090421L NO 20090421 L NO20090421 L NO 20090421L NO 20090421 A NO20090421 A NO 20090421A NO 20090421 A NO20090421 A NO 20090421A NO 20090421 L NO20090421 L NO 20090421L
- Authority
- NO
- Norway
- Prior art keywords
- arylpiperazine derivatives
- compounds
- methods
- arylpiperazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83834306P | 2006-08-17 | 2006-08-17 | |
PCT/EP2007/058158 WO2008019971A2 (en) | 2006-08-17 | 2007-08-07 | Arylpiperazine derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090421L true NO20090421L (no) | 2009-02-06 |
Family
ID=38982453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090421A NO20090421L (no) | 2006-08-17 | 2009-01-28 | Arylpiperazinderivater og deres anvendelse |
Country Status (21)
Country | Link |
---|---|
US (1) | US7754721B2 (ru) |
EP (1) | EP2061774B1 (ru) |
JP (1) | JP4975817B2 (ru) |
KR (1) | KR101077423B1 (ru) |
CN (1) | CN101501008B (ru) |
AR (1) | AR062377A1 (ru) |
AT (1) | ATE492539T1 (ru) |
AU (1) | AU2007286348B2 (ru) |
BR (1) | BRPI0715341A2 (ru) |
CA (1) | CA2660474A1 (ru) |
CL (1) | CL2007002359A1 (ru) |
DE (1) | DE602007011466D1 (ru) |
ES (1) | ES2356098T3 (ru) |
IL (1) | IL196733A0 (ru) |
MX (1) | MX2009001572A (ru) |
NO (1) | NO20090421L (ru) |
PE (1) | PE20080528A1 (ru) |
RU (1) | RU2009104750A (ru) |
TW (1) | TW200815409A (ru) |
WO (1) | WO2008019971A2 (ru) |
ZA (1) | ZA200900960B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8541409B2 (en) | 2007-05-14 | 2013-09-24 | Sk Biopharmaceuticals Co., Ltd. | Carbamoyloxy arylalkanoyl arylpiperazine analgesics |
JP2011512340A (ja) * | 2008-02-15 | 2011-04-21 | エフ.ホフマン−ラ ロシュ アーゲー | 3−アルキルピペラジン誘導体及びその使用 |
SI3154967T1 (sl) | 2014-06-16 | 2020-11-30 | Johnson Matthey Public Limited Company, | Postopki za pripravo alkiliranih arilpiperazinskih in alkiliranih arilpiperidinskih spojin, ki vključujejo nove intermediate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB950872A (en) * | 1961-03-17 | 1964-02-26 | Soc Ind Fab Antibiotiques Sifa | Substituted pyridyl-ethyl-piperazines |
ATE245636T1 (de) * | 1999-07-29 | 2003-08-15 | Lilly Co Eli | Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten |
EP1389189A2 (en) * | 2001-05-22 | 2004-02-18 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
GB0119797D0 (en) | 2001-08-14 | 2001-10-03 | Glaxo Group Ltd | Chemical compounds |
WO2003016274A2 (en) * | 2001-08-21 | 2003-02-27 | Sepracor, Inc. | 2-substituted piperidines that are ligands for monoamine receptors and transporters |
WO2004080407A2 (en) * | 2003-03-07 | 2004-09-23 | Predix Pharmaceuticals Holdings, Inc. | New serotonin modulating compounds and uses therefor |
US7887784B2 (en) * | 2007-03-21 | 2011-02-15 | University Of Montana | 1-[(2′-substituted)-piperazin-1′ -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents |
-
2007
- 2007-08-07 AT AT07788264T patent/ATE492539T1/de active
- 2007-08-07 CA CA002660474A patent/CA2660474A1/en not_active Abandoned
- 2007-08-07 ES ES07788264T patent/ES2356098T3/es active Active
- 2007-08-07 WO PCT/EP2007/058158 patent/WO2008019971A2/en active Application Filing
- 2007-08-07 KR KR1020097003111A patent/KR101077423B1/ko not_active IP Right Cessation
- 2007-08-07 AU AU2007286348A patent/AU2007286348B2/en not_active Ceased
- 2007-08-07 BR BRPI0715341-4A2A patent/BRPI0715341A2/pt not_active IP Right Cessation
- 2007-08-07 MX MX2009001572A patent/MX2009001572A/es active IP Right Grant
- 2007-08-07 DE DE602007011466T patent/DE602007011466D1/de active Active
- 2007-08-07 EP EP07788264A patent/EP2061774B1/en not_active Not-in-force
- 2007-08-07 RU RU2009104750/04A patent/RU2009104750A/ru not_active Application Discontinuation
- 2007-08-07 JP JP2009524170A patent/JP4975817B2/ja not_active Expired - Fee Related
- 2007-08-07 CN CN2007800300771A patent/CN101501008B/zh not_active Expired - Fee Related
- 2007-08-14 TW TW096130027A patent/TW200815409A/zh unknown
- 2007-08-14 CL CL200702359A patent/CL2007002359A1/es unknown
- 2007-08-15 AR ARP070103614A patent/AR062377A1/es unknown
- 2007-08-15 PE PE2007001097A patent/PE20080528A1/es not_active Application Discontinuation
- 2007-08-17 US US11/893,943 patent/US7754721B2/en not_active Expired - Fee Related
-
2009
- 2009-01-26 IL IL196733A patent/IL196733A0/en unknown
- 2009-01-28 NO NO20090421A patent/NO20090421L/no not_active Application Discontinuation
- 2009-02-10 ZA ZA200900960A patent/ZA200900960B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP4975817B2 (ja) | 2012-07-11 |
CN101501008A (zh) | 2009-08-05 |
US7754721B2 (en) | 2010-07-13 |
AU2007286348A1 (en) | 2008-02-21 |
PE20080528A1 (es) | 2008-06-13 |
CA2660474A1 (en) | 2008-02-21 |
BRPI0715341A2 (pt) | 2013-11-26 |
ATE492539T1 (de) | 2011-01-15 |
AR062377A1 (es) | 2008-11-05 |
US20080045543A1 (en) | 2008-02-21 |
KR20090039785A (ko) | 2009-04-22 |
ES2356098T3 (es) | 2011-04-04 |
IL196733A0 (en) | 2009-11-18 |
TW200815409A (en) | 2008-04-01 |
RU2009104750A (ru) | 2010-09-27 |
EP2061774B1 (en) | 2010-12-22 |
WO2008019971A2 (en) | 2008-02-21 |
AU2007286348B2 (en) | 2012-02-09 |
WO2008019971A3 (en) | 2008-05-02 |
ZA200900960B (en) | 2010-01-27 |
JP2010500985A (ja) | 2010-01-14 |
EP2061774A2 (en) | 2009-05-27 |
KR101077423B1 (ko) | 2011-10-26 |
DE602007011466D1 (de) | 2011-02-03 |
CL2007002359A1 (es) | 2008-03-14 |
CN101501008B (zh) | 2011-12-07 |
MX2009001572A (es) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
NO20083726L (no) | Spiroindolinon derivater | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
NO20081554L (no) | Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav | |
NO20082159L (no) | Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser | |
NO20083434L (no) | Benzamid- og heteroarenderivater | |
NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
NO20081315L (no) | Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser | |
NO20064077L (no) | Kemokinreseptorantagonister | |
NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
NO20092058L (no) | Heteroaryl pyrrolidinyl ketonderivater | |
MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
WO2007084728A3 (en) | 2-imino-benzimidazoles | |
NO20082112L (no) | 3-Amino-2-arylpropylazaindoler og deres anvendelse | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
WO2008008660A3 (en) | Cyclopentane derivatives as antiglaucoma agents | |
NO20092226L (no) | Substituerte pyrazol og triazolforbindelser som KSP-inhibitorer | |
TNSN08369A1 (en) | Benzimidazole derivatives | |
NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 | |
NO20080035L (no) | Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |